Xu Qiulin, Liu Jingxian, Guo Xiaohua, Tang Youqing, Zhou Gengbiao, Liu Yanan, Huang Qiaobing, Geng Yan, Liu Zhifeng, Su Lei
Department of ICU, General Hospital of Guangzhou Military Command, Key Laboratory of Tropical Zone Trauma Care and Tissue Repair of PLA, Guangzhou, 510010, China.
Postdoctoral Workstation, Huabo Bio-pharmaceutical Research Institute, Guangzhou, 510515, China.
BMC Complement Altern Med. 2015 Feb 5;15:4. doi: 10.1186/s12906-015-0519-5.
The pathogenesis of heatstroke is a multi-factorial process involved with an interplay among subsequent inflammation, endothelial injury and coagulation disturbances, which makes pharmacological therapy of heatstroke a challenging problem. Xuebijing injection (XBJ), a traditional Chinese medicine used to sepsis, has been reported to suppress inflammatory responses and restore coagulation disturbances. However, little is known about the role of XBJ in heatstroke.
Mice were treated with indicated dose of XBJ before and/or after the induction of heatstroke. Serum inflammatory cytokines, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and endothelial markers, von Willebrand Factor (vWF) and E-selectin, were measured by ELISA. Liver, kidney and heart profiles including alanine aminotransferase, aspartic aminotransferase, creatinine, blood urea nitrogen, and lactate dehydrogenase, were evaluated by UniCel DxC 800 Synchron Clinical Systems, and troponin was measured by ELISA. Coagulation profiles, including thrombin time, prothrombin time, activated partial thromboplastin time, international normalized ratio, and fibrinogen were examined by STA Compact® Hemostasis System. Jejunum injury was evaluated with H&E staining. Changes in mitochondrial structure in cardiac tissue were assesed by electron microscopy.
Pretreatment with XBJ decreased serum pro-inflammatory cytokines including TNF-α and IL-6, as well as endothelial injury markers, vWF and E-selectin, in a dose-dependent manner in heatstroke mice. Similar protective effects were observed when XBJ was administered after, or both before and after heat insult. These protective effects lasted for over 12 h in mice receiving XBJ before and after heat insult. XBJ also improved survival rates in heatstroke mice, ameliorated liver, heart, and kidney injuries, including mitochondrial damage to the heart, and reduced coagulation disturbances.
XBJ prevents organ injuries and improves survival in heatstroke mice by attenuating inflammatory responses and endothelial injury. XBJ may be a potentially useful in the prevention and treatment of heatstroke.
中暑的发病机制是一个多因素过程,涉及后续炎症、内皮损伤和凝血紊乱之间的相互作用,这使得中暑的药物治疗成为一个具有挑战性的问题。血必净注射液(XBJ)是一种用于治疗脓毒症的传统中药,据报道它能抑制炎症反应并恢复凝血紊乱。然而,关于XBJ在中暑中的作用知之甚少。
在中暑诱导之前和/或之后,用指定剂量的XBJ对小鼠进行治疗。通过酶联免疫吸附测定法(ELISA)检测血清炎症细胞因子、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6),以及内皮标志物血管性血友病因子(vWF)和E-选择素。通过UniCel DxC 800同步临床系统评估肝脏、肾脏和心脏指标,包括丙氨酸氨基转移酶、天冬氨酸氨基转移酶、肌酐、血尿素氮和乳酸脱氢酶,并通过ELISA检测肌钙蛋白。通过STA Compact®止血系统检测凝血指标,包括凝血酶时间、凝血酶原时间、活化部分凝血活酶时间、国际标准化比值和纤维蛋白原。用苏木精-伊红(H&E)染色评估空肠损伤。通过电子显微镜评估心脏组织中线粒体结构的变化。
在中暑小鼠中,XBJ预处理以剂量依赖的方式降低了血清促炎细胞因子,包括TNF-α和IL-6,以及内皮损伤标志物vWF和E-选择素。在热损伤后给予XBJ,或在热损伤之前和之后都给予XBJ时,观察到了类似的保护作用。在热损伤前后接受XBJ的小鼠中,这些保护作用持续超过12小时。XBJ还提高了中暑小鼠的存活率,改善了肝脏、心脏和肾脏损伤,包括心脏的线粒体损伤,并减少了凝血紊乱。
XBJ通过减轻炎症反应和内皮损伤来预防中暑小鼠的器官损伤并提高存活率。XBJ可能在中暑的预防和治疗中具有潜在用途。